Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 5/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | FAAH | O00519 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9410608 | 1.00 | PAOX (0.67) | PAOXALDH1A1SOAT1MEN1FAAH | |
| SCHEMBL12488391 | 1.00 | PAOX (0.67) | PAOXALDH1A1SOAT1MEN1FAAH | |
| SCHEMBL22423301 | 1.00 | PAOX (0.67) | PAOXALDH1A1SOAT1MEN1FAAH | |
| SCHEMBL30628038 | 1.00 | PAOX (0.67) | PAOXALDH1A1SOAT1MEN1FAAH | |
| SCHEMBL9410599 | 1.00 | PAOX (0.67) | PAOXALDH1A1SOAT1MEN1FAAH | |
| SCHEMBL23352440 | 1.00 | PAOX (0.67) | PAOXALDH1A1SOAT1MEN1FAAH | |
| SCHEMBL3318564 | 1.00 | PAOX (0.67) | PAOXALDH1A1SOAT1MEN1FAAH | |
| SCHEMBL1327434 | 0.97 | PAOX (0.62) | PAOXALDH1A1SOAT1MEN1FAAH | |
| Acetic Acid SCHEMBL28338186 | 0.95 | PAOX (0.61) | PAOXALDH1A1SOAT1MEN1FAAH | |
| SCHEMBL1326107 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110144033-A1 | Proteasome Inhibitors and Methods of Using the Same | CEPHALON, INC. (US) | 2011-06-16 | — | — | US | claimed |
| US-7915236-B2 | Proteasome inhibitors and methods of using the same | CEPHALON, INC. (US) | 2011-03-29 | — | — | US | claimed |
| EP-1660507-B9 | PROTEASOME INHIBITORS AND METHODS OF USING THE SAME | CEPHALON INC (US) | 2010-03-24 | — | — | EP | claimed |
| US-20090291918-A1 | PROTEASOME INHIBITORS AND METHODS OF USING THE SAME | CEPHALON, INC. (US) | 2009-11-26 | — | — | US | claimed |
| EP-1660507-B1 | PROTEASOME INHIBITORS AND METHODS OF USING THE SAME | CEPHALON INC (US) | 2009-08-05 | — | — | EP | claimed |
| EP-1660507-A2 | PROTEASOME INHIBITORS AND METHODS OF USING THE SAME | CEPHALON, INC. (US) | 2006-05-31 | — | — | EP | claimed |
| US-20050107307-A1 | Proteasome inhibitors and methods of using the same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-05-19 | — | — | US | claimed |
| WO-2005021558-A2 | PROTEASOME INHIBITORS AND METHODS OF USING THE SAME | CEPHALON, INC. (US) | 2005-03-10 | — | — | WO | claimed |
| EP-0772617-B1 | 7-O-CARBAMOYL HEPTOSE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AND SCREENING PROCESS FOR THEIR DETECTION | FORSCH BORSTEL INST FUER EXPER (DE) | 1999-06-23 | — | — | EP | claimed |
| US-20240285584-A1 | AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDERECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS | ALLERGAN, INC. | 2024-08-29 | — | — | US | disclosed |
| US-20220202777-A1 | AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS | ALLERGAN, INC. | 2022-06-30 | — | — | US | disclosed |
| US-10993931-B2 | Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators | ALLERGAN, INC. (US) | 2021-05-04 | — | — | US | disclosed |
| US-20190343804-A1 | AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS | ALLERGAN, INC. | 2019-11-14 | — | — | US | disclosed |
| US-10172832-B2 | Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators | ALLERGAN, INC. (US) | 2019-01-08 | — | — | US | disclosed |
| US-20050107307-A1 | Proteasome inhibitors and methods of using the same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-05-19 | — | — | US | disclosed |
| US-5891892-A | Small molecule biaryl compounds as inhibitors of endothelin converting enzyme | WARNER-LAMBERT COMPANY (US) | 1999-04-06 | — | — | US | disclosed |
| EP-0772617-A1 | 7-O-CARBAMOYL HEPTOSE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AND SCREENING PROCESS FOR THEIR DETECTION | Forschungsinstitut Borstel Institut für Experimentelle Biologie und Medizin (DE) | 1997-05-14 | — | — | EP | disclosed |
| EP-0772617-A1 | 7-O-CARBAMOYL HEPTOSE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AND SCREENING PROCESS FOR THEIR DETECTION | Forschungsinstitut Borstel Institut für Experimentelle Biologie und Medizin (DE) | 1997-05-14 | — | — | EP | disclosed |
| WO-1996002550-A1 | 7-O-CARBAMOYL HEPTOSE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AND SCREENING PROCESS FOR THEIR DETECTION | FORSCHUNGSINSTITUT BORSTEL INSTITUT FÜR EXPERIMENTELLE BIOLOGIE UND MEDIZIN (DE) | 1996-02-01 | — | — | WO | disclosed |
| WO-1996002550-A1 | 7-O-CARBAMOYL HEPTOSE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AND SCREENING PROCESS FOR THEIR DETECTION | FORSCHUNGSINSTITUT BORSTEL INSTITUT FÜR EXPERIMENTELLE BIOLOGIE UND MEDIZIN (DE) | 1996-02-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090291918-A1 | PROTEASOME INHIBITORS AND METHODS OF USING THE SAME | PSMB11, PSMB5, PSMB6 | PAOX 1819/4885ALDH1A1 3935/4885SOAT1 3753/4885 |
| US-20050107307-A1 | Proteasome inhibitors and methods of using the same | PSMB11, PSMB5, PSMB6 | PAOX 1819/4885ALDH1A1 3935/4885SOAT1 3753/4885 |
| US-20190343804-A1 | AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS | FPR1, FPR3, FPR2 | PAOX 2393/4885ALDH1A1 4424/4885SOAT1 3506/4885 |
| US-10172832-B2 | Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators | FPR1, FPR3, FPR2 | PAOX 2393/4885ALDH1A1 4424/4885SOAT1 3506/4885 |
| US-10993931-B2 | Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators | FPR1, FPR3, FPR2 | PAOX 2393/4885ALDH1A1 4424/4885SOAT1 3506/4885 |
| US-20240285584-A1 | AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDERECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS | FPR1, FPR3, FPR2 | PAOX 2011/4885ALDH1A1 4067/4885SOAT1 3194/4885 |
| US-20110144033-A1 | Proteasome Inhibitors and Methods of Using the Same | PSMB11, PSMB5, PSMB6 | PAOX 1819/4885ALDH1A1 3935/4885SOAT1 3753/4885 |
| US-20220202777-A1 | AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS | FPR1, FPR3, FPR2 | PAOX 2393/4885ALDH1A1 4424/4885SOAT1 3506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.